261
Participants
Start Date
April 30, 2010
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
NNZ-2566
"Solution for intravenous infusion.~20 mg/kg intravenous bolus infusion over 10 minutes followed by a continuous intravenous infusion of 1, 3, or 6 mg/kg/h for a total of 72 consecutive hours."
Placebo
Sodium Chloride 0.9% Injection
SUNY Upstate Medical University, Syracuse
University of Pittsburgh Medical Center, Pittsburgh
St Luke's University Hospital, Bethlehem
Inova Fairfax Hospital, Falls Church
Charleston Area Medical Center, Charleston
University of Miami, Lois Pope Life Center, Miami
University of South Alabama, Mobile
University of Cincinnati, Mayfield Clinic, Cincinnati
Miami Valley Hospital, Dayton
Detroit Receiving Hospital and University Health Center, Detroit
Sinai Grace Hospital, Detroit
Bronson Methodist Hospital, Kalamazoo
University of Wisconsin, Froedtert Hospital, Milwaukee
Our Lady of the Lake Hospital, Baton Rouge
Texas Health Harris Methodist Hospital Fort Worth, Fort Worth
University of Arizona, Tucson
Ronald Reagan UCLA Medical Center, Los Angeles
Arrowhead Regional Medical Center, Colton
University of California, Davis Medical Center, Sacramento
The Queen's Medical Center, Honolulu
Lead Sponsor
Neuren Pharmaceuticals Limited
INDUSTRY